A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a ...
The pharmaceutical company said its ceralasertib combination didn’t meet the primary goal of a late-stage clinical trial for ...
Medications like Ozempic mimic a naturally occurring hormone called glucagon-like peptide-1, or GLP-1, which helps regulate ...
City of Hope has launched a national clinical trial network designed to improve cancer care and reach medically-underserved ...
AI’s true promise is turning clinical development from a bottleneck into a throughput engine for human health. Drug discovery ...
Clinical trials continue to shape metastatic breast cancer treatment, making therapies safer, more tolerable, and more ...
A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new ...
A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country's racial and ethnic ...
Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...
Biohaven said on Wednesday its experimental depression drug did not meet the main goal of a mid-stage trial, adding to a string of trial and regulatory setbacks for the drugmaker this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results